Enzon Pharmaceuticals, Inc. (ENZN) Widens Q3 Loss on Lighter Sales
Tweet
Share
E-mailGet Alerts ENZN Hot Sheet
Price: $4.35 --0%
Financial Fact:
Income tax expense (benefit): 5.27M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Income tax expense (benefit): 5.27M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q3 EPS of ($0.19), versus ($0.14) reported last year. Revenue for the quarter came in at $10.44 million, versus $13.23 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance
- GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
